Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Department of Diagnostic Pathology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Oncology. 2024;102(4):354-365. doi: 10.1159/000533791. Epub 2023 Oct 9.
Gastric cancer (GC) remains a common health concern worldwide and is the third leading cause of death in Japan. It can be broadly classified into gastric and intestinal mucin phenotypes using immunohistochemistry. We previously reported numerous associations of kinesin family member (KIF) genes and mucin phenotypes with GC. However, no previous studies have reported on the importance of KIF18B in GC using immunostaining. Thus, in this study, we investigated the expression and functions of KIF18B, which is highly expressed in gastric mucin phenotype GC.
We performed RNA-seq of gastric and intestinal mucin type GCs, and clinicopathological studies of the KIF18B we found were performed using 96 GC cases. We also performed functional analysis using GC-derived cell lines.
RNA-seq showed the upregulation of matrisome-associated genes in gastric mucin phenotype GC and a high expression of KIF18B. KIF18B was detected in 52 of the 96 GC cases (54%) through immunohistochemistry. Low KIF18B expression was significantly associated with poor overall survival (p < 0.01). Other molecules that were significantly associated with KIF18B were MUC5AC and claudin 18; these were also significantly associated with the gastric mucin phenotype. KIF18B small interfering RNA (siRNA)-transfected GC cells showed greater growth and spheroid colony formation than the negative control siRNA-transfected cells. Furthermore, expression of snail family transcriptional repressor 1 and cadherin 2 was significantly increased and that of cadherin 1 was significantly decreased in KIF18B siRNA-transfected GC cells.
These findings not only suggest that KIF18B may be a useful prognostic marker, but also provide insight into the pathogenesis of the GC phenotype.
胃癌(GC)仍然是全球普遍存在的健康问题,也是日本的第三大死亡原因。它可以使用免疫组织化学广泛分为胃型和肠型粘蛋白表型。我们之前报道了许多驱动蛋白家族成员(KIF)基因和粘蛋白表型与 GC 的关联。然而,以前没有研究使用免疫染色报告 KIF18B 在 GC 中的重要性。因此,在这项研究中,我们研究了在胃型粘蛋白表型 GC 中高表达的 KIF18B 的表达和功能。
我们对胃型和肠型粘蛋白型 GC 进行了 RNA-seq,对我们发现的 KIF18B 进行了 96 例 GC 病例的临床病理研究。我们还使用 GC 衍生的细胞系进行了功能分析。
RNA-seq 显示胃型粘蛋白表型 GC 中基质相关基因上调,KIF18B 高表达。通过免疫组织化学检测到 96 例 GC 病例中的 52 例(54%)KIF18B。低 KIF18B 表达与总生存不良显著相关(p < 0.01)。与 KIF18B 显著相关的其他分子是 MUC5AC 和紧密连接蛋白 18;这些也与胃型粘蛋白表型显著相关。KIF18B 小干扰 RNA(siRNA)转染的 GC 细胞比阴性对照 siRNA 转染的细胞生长更快,形成球体集落。此外,在 KIF18B siRNA 转染的 GC 细胞中,snail 家族转录抑制因子 1 和钙粘蛋白 2 的表达显著增加,而钙粘蛋白 1 的表达显著降低。
这些发现不仅表明 KIF18B 可能是一种有用的预后标志物,而且还提供了对 GC 表型发病机制的深入了解。